Curcumin: A potential candidate for matrix metalloproteinase inhibitors

Expert Opinion on Therapeutic Targets

Volumn 16, Issue 10, 2012, Pages 959-972

  Kumar, Dileep ^a   Kumar, Manish ^a   Saravanan, Chinnadurai ^a   Singh, Sushil Kumar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Arthritis; Cancer; Curcumin; MMP; MMPI; Structureactivity relationship; Ulcer

Indexed keywords

CURCUMIN; CYCLIN D1; CYCLOOXYGENASE 2; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTHRITIS; BRAIN CANCER; BREAST CANCER; DRUG BIOAVAILABILITY; DRUG STRUCTURE; HUMAN; IC 50; INFLAMMATION; LUNG CANCER; NEOPLASM; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; STOMACH ULCER;

ANIMALS; CURCUMIN; HUMANS; INFLAMMATION; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84866505237     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2012.710603     Document Type: Review

References (104)

1. Joe B, Vijayakumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 2004;44:97-111 (Pubitemid 38552286)
2. Prakobwong S, Khoontawad J, Yongvanit P, et al. Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis. Int J Cancer 2011;129:88-100
3. Bhutani MK, Bishnoi M, Kulkarni SK. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioural, biochemical and neurochemical changes. Pharmacol Biochem Behav 2009;92:39-43
4. Naz RK. Can curcumin provide an ideal contraceptive?. Mol Reprod Dev 2011;78:116-23
5. Burns J, Joseph PD, Rose KJ. Effect of oral curcumin on Dejerine-Sottas disease. Pediatr Neurol 2009;41:305-8
6. Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353-6 (Pubitemid 28234275)
7. Suresh D, Srinivasan K. Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian J Med Res 2010;131:682-91
8. Durgaprasad S, Pai CG, Vasanthkumar et al. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res 2005;122:315-18 (Pubitemid 43091515)
9. Belkacemi A, Doggui S, Dao L, Ramassam C. Challenges associated with curcumin therapy in Alzheimer disease. Expert reviews in molecular medicine. 2011;13:e34
10. Ao C, Li A, Elzaawely AA, Tawata S. MMP-13 inhibitory activity of thirteen selected plant species from Okinawa. Int J Pharmacol 2008;4:202-7
11. Butler GS, Overall CM. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry 2009;48:10830-45
12. Cauwe B, Opdenakker G. Intracellular substrate cleavage: a novel dimension of the biochemistry, biology and pathology of matrix metalloproteinases. Crit Rev Biochem Mol Biol 2010;45:351-423
13. Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Nat Acad Sci USA 1962;48:1014-22
14. Nagase H, Barrett AJ, Woessner JF Jr. Nomenclature and glossary of the matrix metalloproteinases. Matrix Suppl 1992;1:421-4
15. Saravanan C, Singh SK. Status of research on MMPs in India. Expert Opin Ther Targets 2011;15:715-28
16. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases : structure, function, and biochemistry. Circ Res 2003;92:827-39 (Pubitemid 36542523)
17. Woessner JF. The matrix metalloproteinase family. In: Parks WC, Mecham RP editors Matrix metalloproteinases. Academic Press; San Diego, Calif: 1998. p. 1-13
18. Yodkeeree S, Chaiwangyen W, Garbisa S, Limtrakul P. Curcumin, demethoxycurcumin, and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem 2009;20:87-95
19. Xiao J, Li XK, Chen LH, et al. Effects of curcumin on ECV304 cell's proliferation and expression of matrix metalloproteinase-2. Zhongguo Yaoke Daxue Xuebao 2006;37:268-72 (Pubitemid 43997491)
20. Mohan R, Sivak J, Ashton P, et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 2000;275:10405-12 (Pubitemid 30202100)
21. Girija CR, Karunakar P, Poojari CS, et al. Molecular docking studies of curcumin derivatives with multiple protein targets for procarcinogen activating enzyme inhibition. J Proteomics Bioinformatics 2010;3:200-3
22. Ahonen M, Baker A, Kahari VM. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinaises-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1998;58:2310-15 (Pubitemid 28252684)
23. Gingras D, Renaud A, Mousseau N, et al. Matrix proteinase inhibition by AE-941, a multifunctional antiangiogenic compound. Anticancer Res 2001;21:145-55
24. Kwak HJ, Park MJ, Cho H, et al. Transforming growth factor-b1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and sp1 in human fibrosarcoma cells. Mol Cancer Res 2006;4:209-20
25. Ray S, Chattopadhyay N, Mitra A, et al. Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J Environ Pathol Toxicol Oncol 2003;22:49-58 (Pubitemid 36397493)
26. Philip S, Kundu GC. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem 2003;278:14487-97 (Pubitemid 36800002)
27. Lin SS, Lai KC, Hsu SC, et al. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett 2009;285:127-33
28. Li Z, Wang E, Liu Z, Wu H. Role of ERK1/2 signal pathway in the proliferation-inhibitory effect of curcumin on A549 cells. Bengbu Yixueyuan Xuebao 2011;36:231-4
29. Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 2003;24:1269-79 (Pubitemid 36927068)
30. Lin HJ, Su CC, Lu HF, et al. Curcumin blocks migration and invasion of mouse - rat hybrid retina ganglion cells (N18) through the inhibition of MMP- 2, -9, FAK, Rho A and Rock-1 gene expression. Oncol Rep 2010;23:665-70
31. Woo MS, Jung SH, Kim SY, et al. Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun 2005;335:1017-25
32. Kim SY, Jung SH, Kim HS. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun 2005;337:510-16
33. Bangaru MLY, Chen S, Woodliff J, Kansra S. Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells. Anticancer Res 2010;30:499-504
34. Ibrahim A, El-Meligy A, Fetaih H, et al. Effect of curcumin and Meriva on the lung metastasis of murine mammary gland adenocarcinoma. In Vivo 2010; 24:401-8
35. Aggarwal BB, Shishodia S, Takada Y, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 2005;11:7490-8 (Pubitemid 41507710)
36. Sun ZJ, Chen G, Zhang W, et al. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-kappaB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IkappaB kinase complex signaling axis in adenoid cystic carcinoma. Mol Pharmacol 2011;79:106-18
37. Bang MH, Kim WK. Effect of curcumin on cancer invasion and matrix metalloproteinase-9 activity in MDA-MB-231 human breast cancer cell. Hanguk Yongyang Hakhoechi 2006;39:756-61
38. Sun Y, Fang T, Zhou J, et al. Influence of curcumin on breast cancer cell lines MCF-7 and MDA-MB-231 and the related mechanism. Shan Dong Yi Yao 2011;51:66-7
39. Wang X, Guo B, Zhang X, et al. Hydrazinocurcumin suppresses invasion and migration of human breast cancer MDA-MB-231 cells through inhibiting STAT3 signal pathway. Di-San Junyi Daxue Xuebao 2011;33:111-15
40. Owen JL, Iragavarapu-Charyulu V, Lopez DM. T cell-derived matrix metalloproteinase-9 in breast cancer: friend or foe?. Breast Dis 2004;20:145-53 (Pubitemid 39600454)
41. Di GH, Li HC, Shen ZZ, et al. Analysis of anti-proliferation of curcumin on human breast cancer cells and its mechanism. Zhonghua Yi Xue Za Zhi 2003;83:1764-8
42. Huang MT, Lysz T, Ferraro T, et al. Inhibitory effects of curcumin in vivo lipoxygenase andcyclooxygenase activities in mouse epidermis. Cancer Res 1991;51:813-19
43. Clark CA, McEachern MD, Shah SH, et al. Curcumin inhibits carcinogen and nicotine-induced mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma. Cancer Prev Res 2010;3:1586-95
44. Shin HK, Kim J, Lee EJ, Kim SH. Inhibitory effect of curcumin on motility of human oral squamous carcinoma YD-10B cells via suppression of ERK and NF-kappaB activations. Phytother Res 2010;24:577-82
45. Trudel D, Fradet Y, Meyer F, et al. Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry. Hum Pathol 2008;39:731-9
46. Hong JH, Ahn KS, Bae E, et al. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis 2006;9:147-52 (Pubitemid 43970963)
47. Shankar S, Chen Q, Sarva K, et al. Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis. J Mol Signal 2007;2:10
48. Zhao H, Yu X, Qi R, et al. Inhibitory effects of curcumin in combination with paclitaxel on prostate cancer xenografted model. Xiandai Shengwuyixue Jinzhan 2010;10:823-7
49. Xu F, Mu X, Zhao J Effects of curcumin on invasion and metastasis in the human cervical cancer cells Caski. Chin J Cancer Res 2009;21:159-62
50. Zucker S, Vacirca J Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004;23:101-17 (Pubitemid 38221598)
51. Shehzad A, Khan S, Shehzad O, Lee YS. Curcumin therapeutic promises and bioavailability in colorectal cancer. Drugs Today (Barc) 2010;46:523-32
52. Lin LI, Ke YF, Ko YC, Lin JK. Curcumin inhibits SK-hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 1998;55:349-53
53. Mitra A, Chakrabarti J, Banerji A, et al. Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2. J Environ Pathol Toxicol Oncol 2006;25:679-90
54. Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 2007;67:3853-61 (Pubitemid 46762173)
55. Fossey SL, Bear MD, Lin J, et al. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines. BMC Cancer 2011;11:112
56. Zhou L, Liu Y, Wei Z Effect of curcumin on MT1-MMP-mediated promatrix metalloproteinase-2 activation of tumor-bearing mice. Linchuang Pifuke Zazhi 2007;36:549-52 (Pubitemid 47629033)
57. Saja K, Babu MS, Karunagaran D, Sudhakaran PR. Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. Int Immunopharmacol 2007;7:1659-67 (Pubitemid 350046428)
58. Qi Q, Dai M, Cheng T, et al. Mechanism of curcumin for preventing the expression of mediators of inflammation induced by the particulate debris. Zhongguo Yaolixue Tongbao 2009;25:769-72
59. Qi Q, Dai M, Fan H, et al. Inhibitory effect of curcumin on MMP-2 and MMP-9 expression induced by polyethylene wear particles and its mechanism. Zhongguo Xiufu Chongjian Waike Zazhi 2009;23:677-82
60. Elclaux C, DDelacourt C, D'Ortho M, et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. mJ Respir Cell Mol. Biol 1996; 14:288-95 (Pubitemid 126439823)
61. Wysocki AB, Kusakabe AO, Chang S, et al. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair Regen 1999;7:154-65 (Pubitemid 29331919)
62. Ries C, Egea V, Karow M, et al. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007;109:4055-63 (Pubitemid 46641761)
63. Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 1980;71:632-4 (Pubitemid 10058826)
64. Henrotin Y, Clutterbuck AY, Allaway D, et al. Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage 2010;18:141-9
65. Efthimiou P, Kukar M. Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities. Rheumatol Int 2010;30:571-86
66. Liacini A, Sylvester J, Li WQ, Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kB) transcription factors downregulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 2002;21:251-62 (Pubitemid 34497016)
67. Mun SH, Kim HS, Kim JW, et al. Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: inhibition of the PKCdelta/JNK/c-Jun pathway. J Pharmacol Sci 2009;111:13-21
68. Onodera S, Kaneda K, Mizue Y, et al. Macrophagemigration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000;275:444-50 (Pubitemid 30039004)
69. Moon DO, Kim MO, Choi YH, et al. Curcumin attenuates inflammatory response in IL-1beta -induced human synovial fibroblasts and collagen-induced arthritis in mouse model. Int Immunopharmacol 2010;10:605-10
70. Mix KS, Mengshol JA, Benbow U, et al. A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines. Arthritis Rheum 2001;44:1096-104 (Pubitemid 32433615)
71. Swarnakar S, Ganguly K, Kundu P, et al. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem 2005;280:9409-15 (Pubitemid 40409634)
72. Kundu P, De R, Pal I, et al. Curcumin alleviates matrix metalloproteinase-3 and -9 activities during eradication of Helicobacter pylori infection in cultured cells and mice. PLoS One 2011;6:e16306
73. Baugh MD, Perry MJ, Hollander AP, et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999;117:814-22 (Pubitemid 29468223)
74. Claramunt RM, Bouissane L, Cabildo MP, et al. Synthesis and biological evaluation of curcuminoid pyrazoles as new therapeutic agents in inflammatory bowel disease: effect on matrix metalloproteinases. Bioorg Med Chem 2009;17:1290-6
75. Epstein J, Docena G, MacDonald TT, Sanderson IR. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase - 3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br J Nutr 2010;103:824-32
76. Shi Y, Guo B, Han R, et al. Effect of curcumin capsule on the serum level of matrix metalloproteinase-9 in patients with unstable angina pectoris. Xiandai Zhongxiyi Jiehe Zazhi 2010;19:33-4
77. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9 (Pubitemid 23132154)
78. Yu YM, Lin HC. Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression. Nutr Metab Cardiovasc Dis 2010;20:125-32
79. Jin Ke. Effect of curcumin on expression of myocardial MMP-2 of streptozocin-induced diabetic rats. Guangdong Yixue 2010;31:2636-8
80. Su Y, Hao C, Wang Q, et al. Study on the action mechanism of protective effects of curcumin on kidney of experimental diabetic rats. Hebei Yiyao 2010;32:3123-5
81. Varga J, Whitfield ML. Transforming growth factor-beta in systemic sclerosis (scleroderma). Front Biosci 2009;1:226-35
82. Frost J, Ramsay ML, Mia R, et al. Differential gene expression of MMP-1, TIMP-1 and HGF in clinically involved and uninvolved skin in South Africans with SSc. Rheumatology 2012;51(6):1049-52
83. Lindberg RL, De Groot CJ, Montagne L, et al. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 2001;124(Pt 9):1743-53 (Pubitemid 32845436)
84. Pinlaor S, Prakobwong S, Hiraku Y, et al. Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment. Eur J Pharmacol 2010;638:134-41
85. Li K, Zhang L, Fan Z, Li W. Mechanism of curcumin on inhibiting schistosomiasis liver fibrosis in mice. Zhongguo Difangbingxue Zazhi 2007;26:643-5
86. Rajagopalan R, Sridharana S, Menon VP. Hepatoprotective role of bis-demethoxy curcumin analog on the expression of matrix metalloproteinase induced by alcohol and polyunsaturated fatty acid in rats. Toxicol Mech Methods 2010;20:252-9
87. Aplin AC, Zhu WH, Fogel E, et al. Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis. Am J Physiol Cell Physiol 2009;297:C471-80
88. Swarnakar S, Paul S. Curcumin arrests endometriosis by downregulation of matrix metalloproteinase-9 activity. Indian J Biochem Biophys 2009;46:59-65
89. Jana S, Paul S, Swarnakar S. Curcumin as anti-endometriotic agent: implication of MMP-3 and intrinsic apoptotic pathway. Biochem Pharmacol 2012;83:797-804
90. Xing Z, Zhang J, Zhao F, Liu X. Influence of curcumin on expressions of nuclear factor-kappa B and matrix metallo proteinase-9 mRNA in placenta of premature birth mouse induced with infection. Xiandai Zhongxiyi Jiehe Zazhi 2009;18:1984-6
91. Varani J, Johnson K. A botanical composition for enhanced skin repair and uses thereof. WO 2010/062581;2010
92. Matsuo M, Sakurai H, Koizumi K, Saiki I. Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells. Cancer Lett 2007;251:288-95 (Pubitemid 46669800)
93. Zhao J, Yu S, Lin X, Zhao Y. Effect of curcumin on matrix metalloproteinase 9 and matrix metalloproteinase 2 induced by cerebral ischemia-reperfusion in rats. Zhongfeng Yu Shenjing Jibing Zazhi 2010;27:392-4
94. Lei J, Qin J, Zhang J, et al. Effects of curcumin on inflammatory reaction and blood-brain barrier permeability in rats following cerebral ischemic injury. Zhongguo Yaolixue Tongbao 2010;26:120-3
95. Johnson S, Golub L. Curcumin analogues as zinc chelators and their uses. WO132815A1;2010
96. Anand P, Sung B, Kunnumakkara AB, et al. Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors. Biochem Pharmacol 2011;82:1901-9
97. Worachartcheewan A, Nantasenamat C, Ayudhya CI, et al. Predicting the free radical scavenging activity of curcumin derivatives. Chemom Intell Lab Syst 2011;109:207-16
98. Shen L, Ji HF. Theoretical study on physicochemical properties of curcumin. Spectrochimica Acta Part A 2007;67:619-23 (Pubitemid 46809631)
99. Galano A, Diduk RA, Silva MTR, et al. Role of the reacting free radicals on the antioxidant mechanism of curcumin. Chem Phys 2009;363:13-23
100. Prasanth R, Nair G, Girish CM. Enhanced endocytosis of nano-curcumin in nasopharyngeal cancer cells: an atomic force microscopy study. Appl Phys Lett 2011;99:16
101. Kakkar V, Kaur IP. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol 2011;49:2906-13
102. Li F, Li X, Li B. Preparation of magnetic polylactic acid microspheres and investigation of its releasing property for loading curcumin. J Magn Magn Mater 2011;323:2770-5
103. Mei X, Xu D, Xu S, et al. Gastroprotective and antidepressant effects of a new zinc (II)-curcumin complex in rodent models of gastric ulcer and depression induced by stresses. Pharmacol Biochem Behav 2011;99:66-74
104. Yadav VR, Prasad S, Kannappan R, et al. Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol 2010;80:1021-32